Data_Sheet_1_IL-9 Deficiency Promotes Pulmonary Th17 Response in Murine Model of Pneumocystis Infection.PDF
Pneumocystis pneumonia (PCP) remains a severe complication with high mortality in immunocompromised patients. It has been well accepted that CD4+ T cells play a major role in controlling Pneumocystis infection. Th9 cells were the main source of IL-9 with multifaced roles depending on specific diseases. It is unclear whether IL-9/Th9 contributes to the immune response against PCP. The current study aims to explore the role of IL-9 and the effect of IL-9 on Th17 cells in murine model of PCP.
Materials and methodsMice were intratracheally injected with 1 × 106Pneumocystis organisms to establish the murine model of Pneumocystis infection. Pneumocystis burden was detected by TaqMan real-time PCR. Using IL-9-deficient (IL-9−/−) mice, flow cytometry, real-time PCR and enzyme-linked immunosorbent assay (ELISA) were conducted to investigate the immune function related to Th17 response in defense against Pneumocystis infection.
ResultsReduced Pneumocystis burden was observed in lungs in IL-9−/− mice compared with WT mice at 3-week postinfection. IL-9−/−mice exhibited stronger Th17 immune responses than WT PCP mice through flow cytometer and real-time PCR. ELISA revealed higher levels of IL-17 and IL-23 in bronchoalveolar lavage fluid from IL-9−/− mice than WT mice. And IL-9 deficiency promoted Th17 differentiation from CD4+ naive T cells. IL-17A neutralization increased Pneumocystis burden in IL-9−/− mice.
ConclusionAlthough similar basic clearance of Pneumocystis organisms was achieved in both WT and IL-9−/− PCP mice, IL-9 deficiency could lower Pneumocystis organism burden and promote pulmonary Th17 cells response in the early stage of infection.
History
References
- https://doi.org//10.1056/NEJMra032588
- https://doi.org//10.1378/chest.08-0980
- https://doi.org//10.1016/j.ijid.2016.03.018
- https://doi.org//10.1128/CMR.00013-12
- https://doi.org//10.3109/00365549209052606
- https://doi.org//10.1172/JCI114621
- https://doi.org//10.1086/315487
- https://doi.org//10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#
- https://doi.org//10.4049/jimmunol.177.9.6215
- https://doi.org//10.1002/eji.200839102
- https://doi.org//10.1165/rcmb.2011-0159OC
- https://doi.org//10.1128/IAI.01329-06
- https://doi.org//10.1016/j.celrep.2017.03.016
- https://doi.org//10.1128/IAI.00434-16
- https://doi.org//10.1038/nature04754
- https://doi.org//10.1007/s00281-016-0606-9
- https://doi.org//10.1007/s00281-016-0601-1
- https://doi.org//10.1038/nm.2856
- https://doi.org//10.1111/cea.12787
- https://doi.org//10.1038/mi.2012.84
- https://doi.org//10.1111/imr.12028
- https://doi.org//10.1016/j.cytogfr.2017.07.004
- https://doi.org//10.1038/nature05010
- https://doi.org//10.1073/pnas.0812530106
- https://doi.org//10.1084/jem.20090246
- https://doi.org//10.1165/rcmb.2015-0396OC
- https://doi.org//10.18632/oncotarget.15177
- https://doi.org//10.1016/j.archoralbio.2017.04.003
- https://doi.org//10.1038/ni.2920
- https://doi.org//10.1016/S1074-7613(02)00391-6
- https://doi.org//10.1172/JCI13826
- https://doi.org//10.1016/j.immuni.2013.07.020
- https://doi.org//10.1093/infdis/jiv503
- https://doi.org//10.1016/j.cytogfr.2015.07.005
- https://doi.org//10.1016/S0022-2143(99)90182-8
- https://doi.org//10.1128/IAI.05493-11
- https://doi.org//10.1155/2013/267971
- https://doi.org//10.4049/jimmunol.1301679
- https://doi.org//10.4049/jimmunol.1003307
- https://doi.org//10.1016/j.coi.2009.03.013
- https://doi.org//10.1002/eji.201041125
- https://doi.org//10.1042/CS20140608
- https://doi.org//10.1038/ni.1995
- https://doi.org//10.1016/j.immuni.2007.02.009
- https://doi.org//10.4049/jimmunol.179.7.4313
- https://doi.org//10.1016/j.cytogfr.2014.07.017
- https://doi.org//10.1038/nature04753
- https://doi.org//10.1038/ni.1698
- https://doi.org//10.1016/j.micinf.2006.10.012
- https://doi.org//10.4049/jimmunol.181.9.5948
- https://doi.org//10.1084/jem.20071397
- https://doi.org//10.1165/ajrcmb.23.4.f203
- https://doi.org//10.1172/JCI119384
- https://doi.org//10.1002/eji.201343493
- https://doi.org//10.1084/jem.194.4.519
- https://doi.org//10.4049/jimmunol.0803075
- https://doi.org//10.1128/IAI.00403-09
- https://doi.org//10.1128/IAI.72.10.5722-5732.2004
- https://doi.org//10.1164/ajrccm/139.6.1336
- https://doi.org//10.4049/jimmunol.171.3.1423
- https://doi.org//10.1128/IAI.70.3.1069-1074.2002
- https://doi.org//10.1165/rcmb.2015-0356OC
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity